Home » Stocks » ENZN

Enzon Pharmaceuticals, Inc. (ENZN)

Stock Price: $0.3115 USD 0.0120 (3.83%)
Updated Jan 19, 2021 3:59 PM EST - Market closed
Market Cap 23.12M
Revenue (ttm) 67,000
Net Income (ttm) -1.15M
Shares Out 44.22M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend $0.12
Dividend Yield 38.52%
Trading Day January 19
Last Price $0.3115
Previous Close $0.3000
Change ($) 0.0120
Change (%) 3.83%
Day's Open 0.3100
Day's Range 0.2902 - 0.3300
Day's Volume 50,777
52-Week Range 0.08 - 0.36

News

Hide News
  • All
  • Videos
  • Press Releases
GlobeNewsWire - 2 weeks ago

CRANFORD, N.J., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTC:ENZN) announced today that Andrew Rackear has communicated to the Board his intent to retire from his role as...

GlobeNewsWire - 2 months ago

Looking to Next Step – Acquisition Opportunities Looking to Next Step – Acquisition Opportunities

GlobeNewsWire - 4 months ago

CRANFORD, N.J., Sept. 15, 2020 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (the “Company” or “Enzon”) (OTC:ENZN) announced today the record date and expected subscription period for its ...

GlobeNewsWire - 4 months ago

CRANFORD, N.J., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (the “Company” or “Enzon”) (OTC:ENZN) today announced that its 2020 annual meeting of stockholders (the “Annual...

GlobeNewsWire - 4 months ago

CRANFORD, N.J., Aug. 21, 2020 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (the “Company” or “Enzon”) (OTC: ENZN) today announced that its Board of Directors (the “Board”) has approved a ...

GlobeNewsWire - 5 months ago

CRANFORD, N.J., Aug. 14, 2020 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (the “Company” or “Enzon”) (OTC:ENZN) today announced that its Board of Directors (the “Board”) adopted a tax be...

Seeking Alpha - 1 year ago

ENZN trades at all time highs, adjusted for dividends, and double the "base case" of the liquidation value.

Other stocks mentioned: SESN
Seeking Alpha - 1 year ago

Trading for less than its liquid book value.

About ENZN

Enzon Pharmaceuticals, Inc is a pharmaceutical company engaged in developing therapeutics to patients whose needs are unmet. Its headquarters is now in Piscataway, New Jersey. The company is a publicly traded company on NASDAQ under the symbol "ENZN". It's also doing marketing works in Asia areas such as China. In 2012, the company orally presented in Nanjing, China about the symposium of its drug delivery systems, which help improve therapeutic molecules' pharmaceutical properties. (source: Wikipedia)

Industry
Biotechnology
IPO Date
Feb 15, 1984
CEO
Andrew Rackear
Country
United States
Stock Exchange
OTCMKTS
Ticker Symbol
ENZN
Full Company Profile

Financial Performance

Financial Statements